Clinical Trial Update: Once-a-day Immunosuppression(CISECON_a_day) [Phase 4]

View source ↗

Summary

Phase 4 trial update for once-a-day immunosuppression (CISECON_a_day) in chronic kidney disease; the study NCT01964014 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• CISECON_a_day

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Chronic Renal Disease | Phase 4 | Status: COMPLETED